Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Toyonaga, Takahiko ^a   Matsuura, Minoru ^b   Mori, Kiyoshi ^c   Honzawa, Yusuke ^b   Minami, Naoki ^b   Yamada, Satoshi ^b   Kobayashi, Taku ^a   Hibi, Toshifumi ^a   Nakase, Hiroshi ^d  

^a KITASATO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IL10 PROTEIN, MOUSE; INTERLEUKIN 10; LCN2 PROTEIN, MOUSE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ANIMAL; COLITIS; DISEASE MODEL; ESCHERICHIA COLI; GENE KNOCKOUT; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PHAGOCYTOSIS; PHYSIOLOGY;

ANIMALS; COLITIS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GENE KNOCKOUT TECHNIQUES; HUMANS; INTERLEUKIN-10; LIPOCALIN-2; MACROPHAGES; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS;

EID: 84991661910     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep35014     Document Type: Article

References (49)

1. Sartor, R. B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 3, 390-407 (2006).
2. Spooren, C. E. et al. Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 38, 1172-1187 (2013).
3. Aamodt, G. et al. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol. 168, 1065-1072 (2008).
4. Werner, T. et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut. 60, 325-333 (2011).
5. Flower, D. R., North, A. C. & Sansom, C. E. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta. 1482, 9-24 (2000).
6. Goetz, D. H. et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 10, 1033-1043 (2002).
7. Playford, R. J. et al. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131, 809-817 (2006).
8. Devireddy, L. R., Gazin, C., Zhu, X. & Green, M. R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 123, 1293-1305 (2005).
9. Yang, J. et al. An iron delivery pathway mediated by a lipocalin. Mol Cell. 10, 1045-1056 (2002).
10. Schaible, U. E. & Kaufmann, S. H. Iron and microbial infection. Nat Rev Microbiol. 2, 946-953 (2004).
11. Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 432, 917-921 (2004).
12. Kjeldsen, L., Johnsen, A. H., SengelOv, H. & Borregaard, N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 268, 10425-10432 (1993).
13. Meheus, L. A. et al. Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. J Immunol. 151, 1535-1547 (1993).
14. Chan, Y. R. et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol. 182, 4947-4956 (2009).
15. Chassaing, B. et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. Plos One. 7, e44328 (2012).
16. Nielsen, B. S. et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 38, 414-420 (1996).
17. Ostvik A. E. et al. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin Exp Immunol. 173, 502-511 (2013).
18. Oikonomou, K. A. et al. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol. 47, 519-530 (2012).
19. Bolignano, D. et al. Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. J Investig Med. 58, 569-571 (2010).
20. Nielsen, O. H. et al. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Am J Gastroenterol. 94, 2923-2928 (1999).
21. Valatas, V., Vakas, M. & Kolios, G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 305, G763-G785 (2013).
22. Zigmond, E. et al. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity. 40, 720-733 (2014).
23. Abreu, M. T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol. 10, 131-144 (2010).
24. Cowland, J. B., SOrensen, O. E., Sehested, M. & Borregaard, N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol. 171, 6630-6639 (2003).
25. Cayatte, C. et al. Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease. Clin Transl Gastroenterol. 16, e10 (2012).
26. Stallhofer, J. et al. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status. Inflamm Bowel Dis. 21, 2327-2340 (2015).
27. Obata, Y. et al. Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis. J Immunol. 188, 2427-2436 (2012).
28. Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 12, 503-516 (2012).
29. Singh, V. et al. Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis. Cell Mol Gastroenterol Hepatol. 2, 482-498 (2016).
30. Gautier, E. L. et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol. 13, 1118-1128 (2012).
31. Zhang, J. et al. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol. 22, 1416-1426 (2008).
32. Warszawska, J. M. et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest. 123, 3363-3372 (2013).
33. Deretic, V., Saitoh, T. & Akira, S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 13, 722-737 (2013).
34. Rioux, J. D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39, 596-604 (2007).
35. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39, 207-211 (2007).
36. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 40, 1107-1112 (2008).
37. Lassen, K. G. et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci USA 111, 7741-7746 (2014).
38. Bonilla, D. L. et al. Autophagy regulates phagocytosis by modulating the expression of scavenger receptors. Immunity. 39, 537-547 (2013).
39. Mikami, S. et al. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis. J Pharmacol Exp Ther. 327, 383-392 (2008).
40. Uza, N. et al. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. Gut. 60, 1494-1505 (2011).
41. Sellon, R. K. et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 66, 5224-5231 (1998).
42. Arai, Y., Takanashi, H., Kitagawa, H. & Okayasu, I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine. 10, 890-896 (1998).
43. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodiuminduced colitis in mice. Clin Immunol. 110, 55-62 (2004).
44. Nagashima, K., Hisada, T., Sato, M. & Mochizuki, J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol. 69, 1251-1262 (2003).
45. Nagashima, K., Mochizuki, J., Hisada, T., Suzuki, S. & Shimomura, K. Phylogenetic analysis of 16S ribosomal RNA gene sequences from Human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Bioscience Microflora. 25, 99-107 (2006).
46. Fujimoto, T. et al. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol. 28, 613-619 (2013).
47. Vazquez-Torres, A., Jones-Carson, J., Mastroeni, P., Ischiropoulos, H. & Fang, F. C. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med. 192, 227-236 (2000).
48. Medina-Contreras, O. et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest. 121, 4787-4795 (2011).
49. Bakhautdin, B. et al. Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease. Gut. 62, 209-219 (2013).